Recent investigations by Fang-Ze Wei and Wei Xu have identified CLCA1 and SNHG11 as promising prognostic markers and therapeutic targets in CRC, underscoring the critical role of biomarkers in disease management (19–21). Here, CLCA1 is linked to colorectal carcinoma.